NRNP 6630 Final Exam (Version-1,Latest-2022/2023, 100 Q & A) / NRNP6630 Final Exam / NRNP 6630 Week 11 Final Exam / NRNP6630 Week 11 Final Exam: Walden University | 100% Verified

• NRNP 6630 Final Exam




Question 1 I


0 out of 0 points
I I I I


When completing this exam, did you comply with Walden University’s Code of
I I I I I I I I I I I


Conduct including the expectations for academic integrity?
I I I I I I I


Selected Answer: Yes I




• Question 2 I


1 out of 1 points
I I I I


The PMHNP understands that slow-dose extended release stimulants are most
I I I I I I I I I


appropriate for which patient with ADHD?
I I I I I I


Selected Answer: c. I I


8-year-old patient I




• Question 3 I


1 out of 1 points
I I I I


Jordan is diagnosed with obsessive compulsive disorder. He has been trialed
I I I I I I I I I I


Ion several different SSRIs and is currently on high dose sertraline. He reports
I I I I I I I I I I I I


an inability to carry out responsibilities because of an obsession with handwashing.
I I I I I I I I I I I I


Which is the best treatment option for Jordan?
I I I I I I I I


Selected Answer: a. I I


Maintain the same dose of sertraline and add quetiapine
I I I I I I I I




• Question 4 I


1 out of 1 points
I I I I


The PMHNP is discussing dopamine D2 receptor occupancy and its association with
I I I I I I I I I I I


aggressive behaviors in patients with the student. Why does the PMHNP
I I I I I I I I I I I


prescribe a standard dose of atypical antipsychotics?
I I I I I I I


Selected c. I


Answer:
I The doses are based on achieving 60% D2 receptor I I I I I I I I


occupancy.
I




• Question 5 I


1 out of 1 points
I I I I

,A 72-year-old male patient is in the early stages of Alzheimer’s disease. The
I I I I I I I I I I I I


PMHNP determines that improving memory is a key consideration in selecting
I I I I I I I I I I I


a medication. Which of the following would be an appropriate choice?
I I I I I I I I I I I I


Selected Answer: c. I I


All of these are correct
I I I I




• Question 6 I


1 out of 1 points
I I I I


A 71-year-old male patient comes to an appointment with his 65-year-old wife.
I I I I I I I I I I I


They are both having concerns related to her memory and ability to recognize
I I I I I I I I I I I I I




faces. The PMNHP is considering prescribing memantine (Namenda) based on the
I I I I I I I I I I I


following symptoms:
I I


Selected Answer: c. I I


Amnesia, apraxia, agnosia I I




• Question 7 I


1 out of 1 points
I I I I


The PMHNP is working with the student to care for a patient with diabetic
I I I I I I I I I I I I I


peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not
I I I I I I I I I I I I


consistently useful in treating this particular patient’s pain. What is the best
I I I I I I I I I I I I


response by the PMHNP?
I I I I


Selected Answer: b. I I


“SSRIs only increase serotonin levels.”
I I I I




• Question 8 I


1 out of 1 points
I I I I


The PMHNP is caring for a patient who openly admitted to drinking a quart of vodka
I I I I I I I I I I I I I I I


daily. Prior to prescribing this patient disulfiram (Antabuse), it is important for the
I I I I I I I I I I I I I


PMHNP to:
I I


Selected Answer: b. I I


Evaluate the patient’s willingness to abstain from alcohol
I I I I I I I




• Question 9 I


0 out of 1 points
I I I I


The PMHNP is meeting with the parents of an 8-year-old patient who is
I I I I I I I I I I I I


receiving an initial prescription for D-amphetamine. The PMHNP
I I I I I I I I

, demonstrates appropriate prescribing practices when she prescribes the following
I I I I I I I I I


dose:
I II


Selected Answer: a. I I


The child will take 10–40 mg, daily.
I I I I I I




• Question 10 I


1 out of 1 points
I I I I




The PMHNP is assessing a patient who will be receiving phentermine +
I I I I I I I I I I I


topiramate combination (QSYMIA). QSYMIA would be contraindicated in which
I I I II I I I I I


patient?
I


Selected Answer: d. I I


A 37-year-old female that is being treated with phenelzine
I I I I I I I I




• Question 11 I


0 out of 1 points
I I I I


Jacob is a 7-year-old pediatric patient who has significant oppositional
I I I I I I I I I


symptoms associated with his ADHD diagnosis. What is the best treatment for this
I I I I I I I I I I I I I


patient?
I


Selected Answer: b. I I


Prescribe a methylphenidate alone. I I I




• Question 12 I


1 out of 1 points
I I I I


The PMHNP is attempting to treat a patient’s chronic pain by having the agent
I I I I I I I I I I I I I


bind the open channel conformation of VSCCs to block those channels with a
I I I I I I I I I I I I I




“use-dependent” form of inhibition. Which agent will the PMHNP most likely select?
I I I I I I I I I I I I


Selected Answer: c. I I


Pregabalin (Lyrica) I




• Question 13 I


1 out of 1 points
I I I I


An adult patient presents with a history of alcohol addiction and attention
I I I I I I I I I I I


deficit hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP
I I I I I I I I I




determines which of the following medications may be the best treatment option?
I I I I I I I I I I I I I


Selected Answer: c. I I